Menovar (603538.SH): Mosapride citrate tablets complete drug registration

Zhitongcaijing · 09/03/2025 08:09

Zhitong Finance App News, Minova (603538.SH) announced that Ningbo Menohua Tiankang Pharmaceutical Co., Ltd. (“Menova Tiankang”), a wholly-owned subsidiary of the company, recently received the “Drug Registration Certificate” for moxapride citrate tablets approved and issued by the State Drug Administration. The drug's indications are to improve digestive symptoms caused by decreased gastrointestinal motility (such as functional indigestion, chronic gastritis), including heartburn, belching, nausea, vomiting, early eating, upper abdominal pain, etc.